Discover how neems powerful antibacterial and antifungal properties can transform your skin and hair, offering natural ...

The following is a summary of “Comparative safety of oral Janus kinase inhibitors versus dupilumab in patients with atopic ...

The drawbacks of retinoids involve the potential for irritancy, which can be concentration- and vehicle-dependent.

Sagimet Biosciences eyes major opportunities in MASH and Acne treatments. Find out why SGMT stock is a solid pick with ...

Months of recurring acne in the same spot on my face and one panicked Google search later, I landed upon face mapping—i.e., a ...

DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...

Phase III trial enrolled a total of 480 patients with moderate to severe acne-Topline results expected in the second quarter 2025 HANGZHOU, China, Nov. 12, 2024 ...

Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces completion of enrollment of 480 patients for Phase III clinical trial of ASC40 (denifanstat) once-daily oral tablet for treatment of ...

Getting a diagnosis of hidradenitis suppurativa (HS) can be overwhelming, especially if you’ve never heard of the condition ...

The FDA has approved an antibiotic called minocycline for the treatment of rosacea in adults. The drug, which is taken orally ...

Cystic acne causes large, painful lesions under the skin. Like all acne, it begins with clogged pores, but the cysts are larger and deeper. Unlike typical breakouts, cystic acne can cause significant ...

This is according to CEO Claude Maraoui, who believes the drug “has the potential to become the best-in-class oral medication to treat the condition ... Journey Medical’s portfolio of dermatological ...